Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats
Agnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, et al.
Neuropharmacology (2016) Vol. 113, pp. 188-197
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future
Alvin V. Terry, Patrick M. Callahan
Neuropharmacology (2020) Vol. 170, pp. 108053-108053
Open Access | Times Cited: 72
Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics
Daisy L. Spark, Alex Fornito, Christopher J. Langmead, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators
Dina Manetti, Silvia Dei, Hugo R. Arias, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1270-1270
Open Access | Times Cited: 20
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia
Dean F. Wong, Hiroto Kuwabara, Andrew G. Horti, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 7, pp. 656-667
Open Access | Times Cited: 53
Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies
Agnieszka Potasiewicz, Małgorzata Hołuj, Ewa Litwa, et al.
Neuropharmacology (2020) Vol. 170, pp. 108040-108040
Closed Access | Times Cited: 33
Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery
Alvin V. Terry, Patrick M. Callahan
Nicotine & Tobacco Research (2018) Vol. 21, Iss. 3, pp. 383-394
Open Access | Times Cited: 35
Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
David Phenis, Sarah A. Vunck, Valentina Valentini, et al.
Psychopharmacology (2020) Vol. 237, Iss. 6, pp. 1723-1735
Open Access | Times Cited: 29
Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents
Piotr Popik, Małgorzata Hołuj, Tomasz Kos, et al.
Neurotoxicity Research (2017) Vol. 32, Iss. 4, pp. 544-554
Open Access | Times Cited: 31
An Evolving Therapeutic Rationale for Targeting the α7 Nicotinic Acetylcholine Receptor in Autism Spectrum Disorder
Stephen I. Deutsch, Jessica A. Burket
Current topics in behavioral neurosciences (2020), pp. 167-208
Closed Access | Times Cited: 26
Potential Role of Antipsychotic-Galantamine-Memantine Combination in the Treatment of Positive, Cognitive, and Negative Symptoms of Schizophrenia
Maju Mathew Koola
Complex Psychiatry (2018) Vol. 4, Iss. 3, pp. 134-148
Open Access | Times Cited: 26
α7 Nicotinic Acetylcholine Receptor
Candace M. Jones
Journal of Clinical Psychopharmacology (2018) Vol. 38, Iss. 3, pp. 247-249
Closed Access | Times Cited: 22
In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
Oliwia Koszła, Katarzyna M. Targowska‐Duda, Ewa Kędzierska, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 160-160
Open Access | Times Cited: 20
(E)-3-Furan-2-yl-N-p-tolyl-acrylamide and its Derivative DM489 Decrease Neuropathic Pain in Mice Predominantly by α7 Nicotinic Acetylcholine Receptor Potentiation
Hugo R. Arias, Carla Ghelardini, Elena Lucarini, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 21, pp. 3603-3614
Open Access | Times Cited: 17
Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study
Katarzyna M. Targowska‐Duda, Agnieszka A. Kaczor, Krzysztof Jóźwiak, et al.
Journal of Biomolecular Structure and Dynamics (2018) Vol. 37, Iss. 2, pp. 411-439
Closed Access | Times Cited: 16
Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α7-nicotinic acetylcholine receptors
Agnieszka Potasiewicz, Joanna Gołębiowska, Piotr Popik, et al.
Journal of Psychopharmacology (2018) Vol. 33, Iss. 1, pp. 62-73
Open Access | Times Cited: 16
Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice
Yuanheng Li, Lilan Sun, Taoyi Yang, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 159-173
Closed Access | Times Cited: 15
Blonanserin ameliorates social deficit through dopamine-D3 receptor antagonism in mice administered phencyclidine as an animal model of schizophrenia
Saori Takeuchi, Hirotake Hida, Mizuki Uchida, et al.
Neurochemistry International (2019) Vol. 128, pp. 127-134
Open Access | Times Cited: 14
Effect of nicotine and alpha‐7 nicotinic modulators on visceral pain‐induced conditioned place aversion in mice
Deniz Bağdaş, Julie A. Meade, Yasmin Alkhlaif, et al.
European Journal of Pain (2018) Vol. 22, Iss. 8, pp. 1419-1427
Open Access | Times Cited: 14
Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat
Marie-Louise G. Wadenberg, Dina Manetti, Maria Novella Romanelli, et al.
Behavioural Brain Research (2017) Vol. 333, pp. 129-134
Closed Access | Times Cited: 12
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities
Dina Manetti, Cristina Bellucci, Niccolò Chiaramonte, et al.
Future Medicinal Chemistry (2018) Vol. 10, Iss. 4, pp. 433-460
Open Access | Times Cited: 12
Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats
Katja Savolainen, Jouni Ihalainen, Aaro J. Jalkanen, et al.
Psychopharmacology (2018) Vol. 236, Iss. 4, pp. 1245-1253
Open Access | Times Cited: 12
Ginsenoside Rg1 promotes neurite growth of retinal ganglion cells through cAMP/PKA/CREB pathways
Ye-ying Jiang, Rong-yun Wei, Kai Tang, et al.
Journal of Ginseng Research (2022) Vol. 48, Iss. 2, pp. 163-170
Open Access | Times Cited: 7
Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model
Lilan Sun, Taoyi Yang, Ningning Wei, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 6, pp. 737-745
Open Access | Times Cited: 11
Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation
Katarzyna M. Targowska‐Duda, Barbara Budzyńska, Agnieszka Michalak, et al.
European Neuropsychopharmacology (2021) Vol. 52, pp. 31-47
Closed Access | Times Cited: 9
Cognitive flexibility in humans and other laboratory animals
Quenten Highgate, Susan Schenk
Journal of the Royal Society of New Zealand (2020) Vol. 51, Iss. 1, pp. 97-127
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top